Nutrient quality
Several extract forms are identified, but their active strengths remain incompletely standardized. Low ginkgo and tribulus amounts are the main weakness despite a coherent vitality-oriented blend.
. Daily Vita | $ 23.10 | |
Vitacost | $ 25.97 | |
| $ 23.80 | ||
| $ 24.49 |
Epimedium is the main active, with maca, muira puama, ginseng, damiana, tribulus, ginkgo, and cayenne adding traditional vitality support. All ingredient weights are disclosed.
Tribulus is too low for focused supplementation, and its saponin percentage is absent. Ginkgo is also well below common daily extract amounts and lacks complete standardization.
The larger container and low serving cost strengthen everyday value for libido-oriented use. The formula does not provide convincing hormone or eye-support depth.
Several extract forms are identified, but their active strengths remain incompletely standardized. Low ginkgo and tribulus amounts are the main weakness despite a coherent vitality-oriented blend.
.Active amounts are clearly listed and no proprietary blend hides the supplied doses. Missing daily directions, excipients, and some form or potency details keep disclosure incomplete.
.A strong supplied average is supported by a large review base. Specific review comments were not provided, so repeated complaints and purpose-specific experiences cannot be assessed.
.The long supply and low serving cost support good practical value. Small amounts of the collection-defining extracts limit the value of each dose.
.| Ingredient | Amount per serving |
|---|---|
Epimedium extract (Icariin) | 375 mg |
Muira Puama | 100 mg |
Maca | 100 mg |
Tribulus terrestris extract (Saponins) | 75 mg |
Panax ginseng | 50 mg |
Damiana | 50 mg |
Ginkgo biloba extract (Ginkgoflavonglycosides) | 30 mg |
Cayenne | 25 mg |
Tribulus is only a minor part of this multi-herb blend, so it appears poorly aligned with a dedicated Tribulus choice. The extract amount is very low, and the label does not disclose its saponin concentration or plant part. The low serving cost does not offset the limited potency and incomplete quality details.
The low extract amount is not well aligned with commonly used ginkgo doses. Only one active-marker group is named, without a percentage or purity guarantee. Value for a clinical standardized dose cannot be established. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.